You just read:

New Phase 3 Data Show SIMPONI ARIA® (golimumab) Significantly Improved Signs and Symptoms in Patients with Active Ankylosing Spondylitis

News provided by

Janssen Research & Development, LLC

Nov 14, 2016, 08:00 ET